Pages that link to "Q35143367"

The following pages link to The basic aspects of therapeutics in amyotrophic lateral sclerosis (Q35143367):

Displaying 32 items.

• Multiple Intravenous Administrations of Human Umbilical Cord Blood Cells Benefit in a Mouse Model of ALS (Q28732245) (← links)
• Senataxin mutations and amyotrophic lateral sclerosis (Q34156857) (← links)
• Transgenic rescue of neurogenic atrophy in the nmd mouse reveals a role for Ighmbp2 in dilated cardiomyopathy (Q34311332) (← links)
• Carbonic anhydrase I is recognized by an SOD1 antibody upon biotinylation of human spinal cord extracts (Q34378155) (← links)
• Cognitive impairment in amyotrophic lateral sclerosis (Q34583928) (← links)
• Oxidative stress and the pathogenesis of neurodegenerative disorders (Q34659807) (← links)
• Proteomic analysis reveals differentially regulated protein acetylation in human amyotrophic lateral sclerosis spinal cord (Q35061120) (← links)
• The protective effect of growth hormone on Cu/Zn superoxide dismutase-mutant motor neurons (Q35078519) (← links)
• Autoimmunity in Amyotrophic Lateral Sclerosis: Past and Present (Q35147143) (← links)
• Oxidative Stress in Neurodegeneration (Q35224677) (← links)
• Amyotrophic lateral sclerosis: update for family physicians (Q35613311) (← links)
• Amyotrophic lateral sclerosis: contemporary concepts in etiopathogenesis and pharmacotherapy (Q35964723) (← links)
• Primary lateral sclerosis, hereditary spastic paraplegia and amyotrophic lateral sclerosis: discrete entities or spectrum? (Q36203863) (← links)
• PET imaging studies show enhanced expression of mGluR5 and inflammatory response during progressive degeneration in ALS mouse model expressing SOD1-G93A gene (Q36311020) (← links)
• Biomarkers for amyotrophic lateral sclerosis (Q36481118) (← links)
• Neurodegenerative diseases: neurotoxins as sufficient etiologic agents? (Q36994301) (← links)
• Microglia and motor neurons during disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis: changes in arginase1 and inducible nitric oxide synthase (Q37714667) (← links)
• The frontotemporal syndromes of ALS. Clinicopathological correlates. (Q37910033) (← links)
• NSAIDs in the treatment and/or prevention of neurological disorders (Q37974560) (← links)
• Selective vulnerability of motoneuron and perturbed mitochondrial calcium homeostasis in amyotrophic lateral sclerosis: implications for motoneurons specific calcium dysregulation (Q38521756) (← links)
• Isoform-specific expression and ratio changes accompany oxidant-induced peripherin aggregation in a neuroblastoma cell line (Q39460638) (← links)
• Cerebrospinal Fluid from Sporadic Amyotrophic Lateral Sclerosis Patients Induces Mitochondrial and Lysosomal Dysfunction. (Q40233562) (← links)
• Mutant copper-zinc superoxide dismutase binds to and destabilizes human low molecular weight neurofilament mRNA. (Q40499583) (← links)
• (-)-Deprenyl alleviates the degenerative changes induced in the neonatal rat spinal cord by CSF from amyotrophic lateral sclerosis patients (Q45129350) (← links)
• Calcium signaling pathways mediating synaptic potentiation triggered by amyotrophic lateral sclerosis IgG in motor nerve terminals. (Q46981383) (← links)
• Down regulation of trophic factors in neonatal rat spinal cord after administration of cerebrospinal fluid from sporadic amyotrophic lateral sclerosis patients (Q51829226) (← links)
• Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis. (Q51868850) (← links)
• Phosphorylation of Threonine 175 Tau in the Induction of Tau Pathology in Amyotrophic Lateral Sclerosis-Frontotemporal Spectrum Disorder (ALS-FTSD). A Review. (Q55118636) (← links)
• Profile of laryngological abnormalities in patients with amyotrophic lateral sclerosis (Q79825558) (← links)
• Increased cytotoxic potential of microglia from ALS-transgenic mice (Q80588028) (← links)
• Therapeutic effect of the combined use of growth hormone releasing peptide-6 and epidermal growth factor in an axonopathy model (Q82965730) (← links)
• Dietary supplementation with S-adenosyl methionine delays the onset of motor neuron pathology in a murine model of amyotrophic lateral sclerosis (Q84564661) (← links)